0000821995-10-000047.txt : 20100715
0000821995-10-000047.hdr.sgml : 20100715
20100715152753
ACCESSION NUMBER: 0000821995-10-000047
CONFORMED SUBMISSION TYPE: D
PUBLIC DOCUMENT COUNT: 1
ITEM INFORMATION: Rule 506
FILED AS OF DATE: 20100715
DATE AS OF CHANGE: 20100715
EFFECTIVENESS DATE: 20100715
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: COLUMBIA LABORATORIES INC
CENTRAL INDEX KEY: 0000821995
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 592758596
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: D
SEC ACT: 1933 Act
SEC FILE NUMBER: 021-145047
FILM NUMBER: 10954273
BUSINESS ADDRESS:
STREET 1: 354 EISENHOWER PARKWAY
CITY: LIVINGSTON
STATE: NJ
ZIP: 07039
BUSINESS PHONE: 9739943999
MAIL ADDRESS:
STREET 1: 354 EISENHOWER PARKWAY
CITY: LIVINGSTON
STATE: NJ
ZIP: 07039
D
1
primary_doc.xml
X0704
D
LIVE
0000821995
COLUMBIA LABORATORIES INC
354 EISENHOWER PARKWAY
LIVINGSTON
NJ
NEW JERSEY
07039
9739943999
DELAWARE
Columbia Consumer Pharmaceuticals, Inc.
None
Corporation
true
Frank
C.
Condella
354 Eisenhower Parkway
Plaza 1, Second Floor
Livingston
NJ
NEW JERSEY
07039
Executive Officer
Director
Lawrence
A.
Gyenes
354 Eisenhower Parkway
Plaza 1, Second Floor
Livingston
NJ
NEW JERSEY
07039
Executive Officer
Michael
McGrane
354 Eisenhower Parkway
Plaza 1, Second Floor
Livingston
NJ
NEW JERSEY
07039
Executive Officer
Stephen
G.
Kasnet
354 Eisenhower Parkway
Plaza 1, Second Floor
Livingston
NJ
NEW JERSEY
07039
Director
Edward
A.
Blechschmidt
354 Eisenhower Parkway
Plaza 1, Second Floor
Livingston
NJ
NEW JERSEY
07039
Director
Valerie
L.
Andrews
354 Eisenhower Parkway
Plaza 1, Second Floor
Livingston
NJ
NEW JERSEY
07039
Director
Anthony
R.
Campbell
354 Eisenhower Parkway
Plaza 1, Second Floor
Livingston
NJ
NEW JERSEY
07039
Director
James
S.
Crofton
354 Eisenhower Parkway
Plaza 1, Second Floor
Livingston
NJ
NEW JERSEY
07039
Director
Selwyn
P.
Oskowitz, M.D.
354 Eisenhower Parkway
Plaza 1, Second Floor
Livingston
NJ
NEW JERSEY
07039
Director
Pharmaceuticals
Decline to Disclose
- 06
false
2010-07-02
false
true
true
false
9573
24528629
24528629
0
Only for purposes of this Form D, the shares of Common Stock are valued at $1.03 per share (the closing price on July 2, 2010) and the warrants are valued at $0.692 per warrant.
false
25
0
0
As more fully described in Columbia Laboratory, Inc.'s (the "Company") proxy statement, dated June 1, 2010, the Company paid Torreya Partners LLC a fee for investment banking services as described in that proxy statement.
1624246
true
In exchange for $5,000,000 of the Company's notes, Dorset Management Corp. & David Knott, affiliates of Anthony R. Campbell (a member of the Company's board) received $3,250,000, 925,926 shares of Common Stock & warrants to purchase 7,750,000 shares.
false
COLUMBIA LABORATORIES INC
Frank C Condella, Jr
Frank C Condella, Jr
President & CEO
2010-07-13